2,4-Dienoyl-CoA reductase 1 (DECR1) can limit the rate of PUFA oxidation, and its expression is significantly increased in prostate tumors and castration-resistant mice, but the opposite is observed in breast cancer [76, 77]. The gene discussed is DECR1; the disease is prostate neoplasm.